Shawn Singh - Jun 28, 2024 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Jun 28, 2024
Transactions value $
$14,358
Form type
4
Date filed
7/2/2024, 06:06 PM
Previous filing
Jun 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $14.4K +4.85K +86.17% $2.96 10.5K Jun 28, 2024 Direct F1
holding VTGN Common Stock 20.9K Jun 28, 2024 By The 1997 Singh Family Trust U/R/D 05/29/97
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended.